Stocktoria
Earth Science Tech, Inc. ETST
OTC · OOTC · stock · Pharmaceutical Preparations · website · IPO 2012-08-29
Earth Science Tech, Inc. financials (annual, from 10-K)
Bars are annual figures from 2015 to 2026; red bars are negative (a loss or cash outflow).
| Metric | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $35.7M | $33.1M | $12.0M | $48,537 | $14,123 | $140,902 | $526,139 | $770,635 | $463,108 | $80,279 |
| Gross profit | $25.5M | $24.3M | $7.8M | $22,060 | -$8,516 | $39,934 | $218,474 | $295,013 | $192,886 | $3,219 |
| R&D expense | — | — | — | $0 | $0 | $9,000 | $76,113 | $338,856 | $150,451 | $32,593 |
| SG&A expense | $3.6M | $4.2M | $166,976 | $231,890 | — | — | — | — | — | — |
| Operating income | — | — | $892,349 | -$936,683 | -$226,706 | -$4.3M | -$908,567 | -$2.1M | -$1.7M | -$8.5M |
| Interest expense | — | — | $67,207 | $47,433 | $86,706 | $4,765 | $4,765 | $75,632 | $4,765 | $4,730 |
| Income tax | -$511,676 | $116,776 | $13,003 | — | — | — | — | — | — | — |
| Net income | $3.6M | $3.3M | $812,139 | -$365,405 | $3.2M | -$4.4M | -$1.2M | -$2.2M | -$1.7M | -$8.5M |
| EPS (diluted) | $0.01 | $0.01 | $0.00 | $-0.00 | — | — | — | — | — | — |
| Operating cash flow | $1.9M | $4.4M | $1.2M | -$1.0M | -$168,106 | -$196,686 | -$518,620 | -$1.6M | -$1.1M | -$376,355 |
| Free cash flow | $1.2M | $3.6M | $1.2M | — | — | — | — | — | — | -$445,338 |
| Cash & equivalents | $796,797 | $1.5M | — | $35,756 | $26,942 | $16,161 | $30,723 | — | — | — |
| Inventory | $682,059 | $503,938 | $315,738 | $10,260 | — | $21,739 | $63,348 | $161,309 | — | — |
| Total assets | $9.0M | $7.1M | $3.9M | $2.7M | $76,942 | $64,564 | $154,552 | $411,071 | $345,326 | $773,728 |
| Total liabilities | $1.9M | $3.2M | $1.6M | $1.6M | $1.9M | $5.1M | $980,351 | $617,730 | $465,307 | $148,213 |
| Shareholders' equity | $7.0M | $3.9M | $2.2M | $1.1M | -$1.8M | -$5.0M | -$825,799 | -$206,659 | -$119,981 | $625,515 |
Growth · year-over-year · Revenue CAGR 96.9%
| Metric | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +7.8% | +177.1% | +24527.9% | +243.7% | -90.0% | -73.2% | -31.7% | +66.4% | +476.9% | +977.6% |
| Net income growth | +11.6% | +300.6% | — | -111.5% | — | — | — | — | — | — |
| EPS growth | +9.1% | +266.7% | — | — | — | — | — | — | — | — |
| Free cash flow growth | -67.3% | +206.8% | — | — | — | — | — | — | — | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Source: SEC EDGAR filings · CIK 0001538495 · as of 2026-03-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.